These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24024893)

  • 1. A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
    Dendrou CA; Bell JI; Fugger L
    Pharmacogenomics; 2013 Sep; 14(12):1397-404. PubMed ID: 24024893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
    Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L
    Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
    Caminero A; Comabella M; Montalban X
    Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.
    Magliozzi R; Howell OW; Durrenberger P; Aricò E; James R; Cruciani C; Reeves C; Roncaroli F; Nicholas R; Reynolds R
    J Neuroinflammation; 2019 Dec; 16(1):259. PubMed ID: 31810488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
    Magliozzi R; Pezzini F; Pucci M; Rossi S; Facchiano F; Marastoni D; Montagnana M; Lippi G; Reynolds R; Calabrese M
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration.
    Dong Y; Fischer R; Naudé PJ; Maier O; Nyakas C; Duffey M; Van der Zee EA; Dekens D; Douwenga W; Herrmann A; Guenzi E; Kontermann RE; Pfizenmaier K; Eisel UL
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12304-12309. PubMed ID: 27791020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.
    Kümpfel T; Hohlfeld R
    Nat Rev Neurol; 2009 Oct; 5(10):528-9. PubMed ID: 19794511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct modes of TNF signaling through its two receptors in health and disease.
    Atretkhany KN; Gogoleva VS; Drutskaya MS; Nedospasov SA
    J Leukoc Biol; 2020 Jun; 107(6):893-905. PubMed ID: 32083339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis.
    Williams SK; Maier O; Fischer R; Fairless R; Hochmeister S; Stojic A; Pick L; Haar D; Musiol S; Storch MK; Pfizenmaier K; Diem R
    PLoS One; 2014; 9(2):e90117. PubMed ID: 24587232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis.
    Williams SK; Fairless R; Maier O; Liermann PC; Pichi K; Fischer R; Eisel ULM; Kontermann R; Herrmann A; Weksler B; Romero N; Couraud PO; Pfizenmaier K; Diem R
    Sci Rep; 2018 Sep; 8(1):13628. PubMed ID: 30206422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer.
    Walczak H
    Immunol Rev; 2011 Nov; 244(1):9-28. PubMed ID: 22017428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
    Ottoboni L; Frohlich IY; Lee M; Healy BC; Keenan BT; Xia Z; Chitnis T; Guttmann CR; Khoury SJ; Weiner HL; Hafler DA; De Jager PL
    Neurology; 2013 Nov; 81(22):1891-9. PubMed ID: 24174586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.
    Oshima H; Ishikawa T; Yoshida GJ; Naoi K; Maeda Y; Naka K; Ju X; Yamada Y; Minamoto T; Mukaida N; Saya H; Oshima M
    Oncogene; 2014 Jul; 33(29):3820-9. PubMed ID: 23975421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
    Noguchi T; Tsuchida M; Kogue Y; Spadini C; Hirata Y; Matsuzawa A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli.
    Housley WJ; Fernandez SD; Vera K; Murikinati SR; Grutzendler J; Cuerdon N; Glick L; De Jager PL; Mitrovic M; Cotsapas C; Hafler DA
    Sci Transl Med; 2015 Jun; 7(291):291ra93. PubMed ID: 26062845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina.
    Kauffman MA; Gonzalez-Morón D; Garcea O; Villa AM
    Mol Biol Rep; 2012 Jan; 39(1):117-21. PubMed ID: 21567205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
    Kang X; Ploner A; Pedersen NL; Bandres-Ciga S; Noyce AJ; Wirdefeldt K; Williams DM
    Neurology; 2021 Mar; 96(12):e1672-e1679. PubMed ID: 33608417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
    Ke F; Zhang L; Liu Z; Yan S; Xu Z; Bai J; Zhu H; Lou F; Cai W; Sun Y; Gao Y; Wang H; Wang H
    Stem Cells Transl Med; 2016 Mar; 5(3):301-13. PubMed ID: 26819253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story.
    Caminero A; Comabella M; Montalban X
    J Neuroimmunol; 2011 May; 234(1-2):1-6. PubMed ID: 21474190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.